97091 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Protease inhibitors; Endopeptidase (E.C. 3.4.21-99) inhibitors Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
GENETICALLY MODIFIED CELLS COMPRISING A NUCLEIC ACID ENCODING A CD40L BINDING AGENT AND USES THEREOF
#2METHODS AND COMPOSITIONS FOR THE DETECTION AND DIAGNOSIS OF RENAL DISEASE AND PERIODONTAL DISEASE
#3SCAFFOLD PROTEINS
#4ANTICANCER PEPTIDE AND USE IN TREATING CANCER
#5CYSTATIN RNA COMPOSITIONS FOR TISSUE ENGINEERING
#6HUMANIZED ANTIBODY INHIBITORS FOR CATHEPSIN S
#7Scaffold proteins
#8MULTI-DOMAIN PROTEIN VACCINE
#9MEMBRANE PROTEIN TARGETING ENGINEERED DEUBIQUITINASES AND METHODS OF USE THEREOF
#10INHIBITORS OF CYSTEINE PEPTIDASES ISOLATED FROM NATURAL RAW MATERIALS AND USE OF THE INHIBITORS IN MEDICINE AND VETERINARY MEDICINE
#11THERAPEUTIC NANOCONJUGATES AND USES THEREOF
#12METHODS AND COMPOSITIONS FOR THE DETECTION AND DIAGNOSIS OF RENAL DISEASE AND PERIODONTAL DISEASE
#13Cystatin C and Cystatin 9 to treat gut inflammation caused by thermal injury
#14Scaffold proteins
#15Microorganism for delivering drug for treatment of gastrointestinal disease, which expresses and secretes cystatin, and pharmaceutical composition for preventing or treating gastrointestinal disease, which includes the same
#16Methods and composition for detecting CAPN5
#17MESSENGER RIBONUCLEIC ACIDS FOR THE PRODUCTION OF INTRACELLULAR BINDING POLYPEPTIDES AND METHODS OF USE THEREOF
#18Selective cysteine protease inhibitors and uses thereof
#19Preventing, Treating or Arresting Alzheimer's, Stroke, Cardiovascular and other Amyloid Related Diseases
#20Methods and compositions for the detection and diagnosis of renal disease and periodontal disease
#21Polypeptides, related nucleic acids, and their uses for cell modulation and treatments
#22MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF INTRABODIES
#23Peptides for the treatment of neurodegenerative diseases
#24Selective caspase inhibitors and uses thereof
#25Target for Firmicutes and Related Bacteria: The PRP Protease
#26IAP antagonists
#27Modified Stefin A scaffold proteins
#28Anti-inflammatory proteins and peptides and methods of preparation and use thereof
#29METHODS FOR DIAGNOSING AND/OR TREATING STERILITY
#30Kidney disease biomarker
#31Selective caspase inhibitors and uses thereof
#32Inhibitors against endosomal/lysosomal enzymes
#33Methods and compositions for transgenic plants with enhanced resistance to biotic and abiotic stress
#34Methods, systems, and compositions for calpain inhibition
#35Selective cysteine protease inhibitors and uses thereof
#36Method of treating metastatic cancer
#37Anti-pathogen systems
#38Cystatin C, β2 microglobulin, α1 microglobulin and genes for same, antibody, and kit and method for diagnosis of feline nephropathy
#39MEANS FOR PREVENTING AND TREATING CELLULAR DEATH AND THEIR BIOLOGICAL APPLICATIONS
#40CYSTATIN C AS AN ANTAGONIST OF TGF-BETA AND METHODS RELATED THERETO
#41NOVEL CASPASE-2 INHIBITORS
#42Scaffold polypeptides for heterologous peptide display
#43Selective caspase inhibitors and uses thereof
#44Biomarkers, methods and kits for the diagnosis of rheumatoid arthritis
#45Methods, systems, and compositions for calpain inhabition
#46Biomarkers for diagnosing alzheimer's disease
#47Anti-apoptotic fusion proteins for reducing myocardial infarction size
#48FIBROMYALGIA TEST METHOD
#49Polynucleotide encoding a cysteine protease
#50Selective caspase inhibitors and uses thereof
#51Modified Stefin A scaffold proteins
#52Maize cystatin promoter for pericarp preferred expression
#53Cystatin C as an antagonist of TGF-β and methods related thereto
#54Polypeptide comprising a knottin protein moiety
#55Methods for diagnosis and optimizing treatment of multiple sclerosis
#56MEANS FOR PREVENTING AND TREATING CELLULAR DEATH AND THEIR BIOLOGICAL APPLICATIONS
#57Methods for making recombinant proteins using apoptosis inhibitors
#58METHODS AND COMPOSITIONS FOR THE INHIBITION OF CATHEPSINS
#59Cystatin C as an antagonist of TGF-β and methods related thereto
#60Mutant proline-and-arginine rich peptides and methods for using the same
#61Inhibitors of enveloped virus infectivity
#62Inhibition of viral replication
#63Scaffold polypeptides for heterologous peptide display
#64Method of cancer treatment by p53 protein control
#65Calpastatin (CAST) alleles
#66Crop Plant Cystatin Proteinase Inhibitors and Methods of Use
#67CeCPI: taro cysteine protease inhibitor
#68Methods of diagnosing or prognosticating age-related macular degeneration
#69Castanea sativa mill. genes codifying for allene oxide cyclase, cystatin, beta-1, 3-glucanase and thaumatin-like protein and their use
#70Method for PR-39 peptide mediated selective inhibition of IkappaBalpha degradation
#71Modulation of coffee flavour precursor levels in green coffee grains
#72Methods for making recombinant proteins using apoptosis inhibitors
#73Method for separating and concentrating biological materials using continuous-flow ultracentrifugation
#74Means for preventing and treating cellular death and their biological applications
#75Biomarkers for diagnosing alzheimer's disease
#76Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent
#77Function of autophagy genes in cell death
#78Cystatin C as an antagonist of TGF-β and methods related thereto
#79Human cystatin F
#80Protease inhibitor
#81Crop plant cystatin proteinase inhibitors encoding nucleic acids and methods of use
#82Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent
#83Temperature-stable glycosylated recombinant chicken cystatin and the use thereof